#### January 12, 2023
#### Davos, Switzerland
## Novartis leadership will be at the World Economic Forum (WEF) Annual Meeting
January 16-20, 2023 | Davos, Switzerland
---
[Novartis Focus](#cooperation)| [Future of Health Systems](#future)| [Events and Panels](#events)| [In the News](#news)
---
## “Cooperation in a Fragmented World”
Our focus at WEF is to explore how more people can have access to transformative treatments, faster.
We will highlight the various ways this can be achieved at systemic levels across some of the world's toughest healthcare challenges.
WEF2023 Annual Meeting provides a platform to engage in constructive, forward-looking dialogues and help find solutions through public-private cooperation.
---
## Future of Health Systems
Our thought-leadership and actions are industry leading.
Here are a some of the systemic ways we are reimagining medicine to improve and extend people's lives
### The future of medicine is here
**Vas Narasimhan**, LinkedIn article
[Read Article on LinkedIn](https://www.linkedin.com/pulse/future-medicine-here-vas-narasimhan)
### Why the pharmaceutical industry must partner with public healthcare to improve patient health
**Marie-France Tschudin**, President, Innovative Medicines International and Chief Commercial Officer
[Read Article on WEF](https://www.weforum.org/agenda/2023/01/public-health-systems-and-pharmaceutical-industry-must-work-together-davos23)
### Urban population health initiative delivers significant reductions in heart disease
**CARDIO4Cities**, Novartis Foundation
[Read Article](https://www.novartisfoundation.org/news/media-release/urban-population-health-initiative-delivers-significant-reductions-heart-disease)
### Tackling health poverty risks in Africa: 4 experts weigh in
**Lutz Hegemann**, President, Global Health and Sustainability, Novartis
[Read Article](https://www.weforum.org/agenda/2023/01/autonomy-is-a-game-changer-for-health-systems-in-africa-davos2023/)
> ..looking towards a healthier future within reach, we know business is key to translating science into widespread human progress.
>
> **Vas Narasimhan**
> Public health systems and pharmaceutical companies are at a crossroads. Both must adapt and re-focus on patients.
>
> **Marie-France Tschudin**
> Conducting business with integrity is of paramount importance and, as a focused medicines company, essential to our patients, partners and associates.
>
> **Klaus Moosmayer**
> Heart disease and the need for more equitable healthcare systems are two such issues which require our attention to make the world a better and more sustainable place.
>
> **Joerg Reinhardt**
> Public-private partnerships are essential to driving investments in high-quality healthcare, medicines, services and innovations required to build resilient and equitable health systems.
>
> **Lutz Hegemann**
> It's important to start with the right problem statement in all aspects of health, but specifically in population health.
>
> **Ann Aerts**
---
## Events and Panels
**The Future of Health: Unlocking the power of data to improve urban health**
January 17, 2023 14:00 CET
Live WEF Panel
hosted by Novartis Foundation
[Watch the Recording](https://www.youtube.com/watch?v=XGIZytEjB04)
**Health Systems: Building through Disruption**
January 18, 2023 16:15–17:00 CET
Live WEF Panel
[Watch the Recording](/news/world-economic-forum-2023/health-systems-building-through-disruption "Health Systems: Building through Disruption")
**Meet the Leaders Podcast: Marie-France Tschudin**
TBD
World Economic Forum Podcast
[Link available on TBD](#)
**Health Equity as an Essential Component of Stakeholder Capitalism**
January 18, 2023 14:30 CET
Live WEF Panel
hosted by Deloitte
[Watch the Recording](https://www.linkedin.com/video/event/urn:li:ugcPost:7017618153023176704/)
---
## In the News
[
### Confronting the world’s number one killer: cardiovascular disease
POLITICO Studio spoke to members of the Council for Heart Health, an inclusive group of experts committed to reducing the burden of cardiovascular disease through multidisciplinary collaboration.
](https://www.politico.eu/sponsored-content/confronting-the-worlds-number-one-killer-cardiovascular-disease/)
[
### Novartis CEO says Covid to become endemic, calls for better pandemic preparedness
“I think what we’re going to settle into is more of an endemic environment with respect to coronaviruses and the Covid virus specifically,” Vas Narasimhan, CEO of Novartis, told CNBC at the World Economic Forum in Davos, Switzerland.
](https://www.cnbc.com/2023/01/19/novartis-ceo-says-covid-to-become-endemic-calls-for-better-pandemic-preparedness.html?utm_term=Autofeed&utm_medium=Social&utm_content=Main&utm_source=Twitter#Echobox=1674117069)
[
### Novartis CEO: Nations pulling back on health care spending ‘has long-term consequences'
Novartis CEO Vasant Narasimhan joins Yahoo Finance Live's Julie Hyman at the 2023 World Economic Forum in Davos, Switzerland, to discuss drug pricing, the future of medicine, the impact that health can have on economies, growth, and the outlook for the health care industry.
](https://ca.finance.yahoo.com/video/novartis-ceo-nations-pulling-back-165937994.html)
## Related Content
[
### Access
Through our core business – the discovery, development and marketing of innovative treatments – we have helped prevent and treat diseases, ease suffering and improve quality of life for people worldwide.
](/esg/access)
### Environmental, Social and Governance
At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues.
[
### Strategy
Our strategy is to deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.
](/about/strategy)
## Follow our Conversation on Social
**Novartis:** [Twitter](https://twitter.com/novartis) | [LinkedIn](https://www.linkedin.com/company/novartis)
**Vas Narasimhan**, Chief Executive Officer: [Twitter](https://twitter.com/VasNarasimhan) | [LinkedIn](https://www.linkedin.com/in/vasnarasimhan/)
**Marie-France Tschudin**, President, Innovative Medicines International & Chief Commercial Officer: [LinkedIn](https://www.linkedin.com/in/mariefrancetschudin/)
**Klaus Moosmayer**, Chief Ethics, Risk & Compliance Officer: [LinkedIn](https://www.linkedin.com/in/klaus-moosmayer-73399b15b/)
**Novartis Foundation:** [Twitter](https://twitter.com/NovartisFDN) | [LinkedIn](https://www.linkedin.com/company/novartis-foundation/)
**Ann Aerts**, Head of Novartis Foundation: [LinkedIn](https://www.linkedin.com/in/aaerts/)